Sort   by:  
 Page size 
UnknownSexual health and COVID-19: protocol for a scoping review.
Not available
S-EPMC7825389 | biostudies-literature
UnknownA recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia.
Not available
S-EPMC3919799 | biostudies-literature
UnknownAssociation of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.
Not available
S-EPMC7972830 | biostudies-literature
UnknownInterplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.
Not available
S-EPMC9634600 | biostudies-literature
UnknownImmune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma.
Not available
S-EPMC6839732 | biostudies-literature
UnknownMutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.
Not available
S-EPMC5957269 | biostudies-literature
UnknownCYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers.
Not available
S-EPMC7884683 | biostudies-literature
UnknownThe <i>FANCM</i>:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.
Not available
S-EPMC6825205 | biostudies-literature
UnknownFine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.
Not available
S-EPMC6974400 | biostudies-literature
UnknownAssessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.
Not available
S-EPMC4382299 | biostudies-literature
Sort   by:  
 Page size